Table 2 Bladder stress–associated receptors and neurotrophin expression in patients with IC/BPS and control patients.
(A) Controls (N = 24) | (B) NHIC (N = 51) | (C) HIC (N = 23) | Total IC/BPS (N = 74) | P value* | P value** | Post hoc | |
|---|---|---|---|---|---|---|---|
CRHR1 | 1.14 ± 0.52 | 1.34 ± 1.72 | 2.90 ± 1.43 | 1.82 ± 1.78 | 0.004 | <0.001 | A vs B = 0.89 A vs C < 0.001 B vs C < 0.001 |
CRHR2 | 0.55 ± 0.45 | 0.31 ± 0.48 | 0.21 ± 0.32 | 0.28 ± 0.43 | 0.01 | 0.03 | A vs B = 0.10 A vs C = 0.04 B vs C = 0.67 |
NGF | 0.83 ± 0.61 | 0.61 ± 0.42 | 1.32 ± 0.79 | 0.83 ± 0.65 | 0.99 | <0.001 | A vs B = 0.29 A vs C = 0.02 B vs C < 0.001 |
E-cadherin | 0.60 ± 0.26 | 0.31 ± 0.30 | 0.19 ± 0.20 | 0.27 ± 0.28 | <0.001 | <0.001 | A vs B < 0.001 A vs C < 0.001 B vs C = 0.20 |